In yesterday’s Wall Street session, Bristol-Myers Squibb Co. (NYSE:BMY) shares traded at $42.27, down -2.51% from the previous session.
BMY stock price is now -13.18% away from the 50-day moving average and -19.71% away from the 200-day moving average. The market capitalization of the company currently stands at $85.69B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On February 06, 2024, Redburn Atlantic Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $77 to quote $54, while ‘BofA Securities’ rates the stock as ‘Neutral’
In other news, BOERNER CHRISTOPHER S., Chief Executive Officer bought 2,000 shares of the company’s stock on Dec 05 ’23. The stock was bought for $99,560 at an average price of $49.78. Upon completion of the transaction, the Chief Executive Officer now directly owns 82,672 shares in the company, valued at $3.49 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 28 ’23, Chief Executive Officer BOERNER CHRISTOPHER S. bought 3,071 shares of the business’s stock. A total of $150,049 was incurred on buying the stock at an average price of $48.86. This leaves the insider owning 79,384 shares of the company worth $3.36 million. A total of 0.07% of the company’s stock is owned by insiders.
During the past 12 months, Bristol-Myers Squibb Co. has had a low of $43.31 and a high of $67.16. As of last week, the company has a debt-to-equity ratio of 3.48, a current ratio of 1.11, and a quick ratio of 0.99. The fifty day moving average price for BMY is $48.4442 and a two-hundred day moving average price translates $52.5562 for the stock.
The latest earnings results from Bristol-Myers Squibb Co. (NYSE: BMY) was released for 2024-03-31. According to the Drug Manufacturers – General Company, earnings per share came in at 1.75, missing analysts’ expectations of 1.98 by -0.23. This compares to $1.07 EPS in the same period last year. The net profit margin was -13.50% and return on equity was -25.45% for BMY. The company reported revenue of $11.87 billion for the quarter, compared to $11.34 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 4.66 percent. For the current quarter, analysts expect BMY to generate $11.52B in revenue.
